Vilket är priset för Dong Sung Bio Pharm.Co.,Ltd. (002210)

Priset för Dong Sung Bio Pharm.Co.,Ltd. (002210) är $1.11

Vilket är marknadsvärdet för Dong Sung Bio Pharm.Co.,Ltd. (002210)

Marknadsvärdet för Dong Sung Bio Pharm.Co.,Ltd. (002210) är $27.17M

Dong Sung Bio Pharm.Co.,Ltd. (002210) P/S-tal

Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.

År	P/S-tal	Ändra
2026 (TTM)	0.52	-57.06%
2024	1.20	-21.39%
2023	1.52	-7.79%
2022	1.65	-28.83%
2021	2.32	-30.28%
2020	3.33	-22.20%
2019	4.28	24.56%
2018	3.43	173.39%
2017	1.26	20.04%
2016	1.05	-20.02%
2015	1.31	20.62%
2014	1.08	34.07%
2013	0.81	-0.50%
2012	0.81	155.32%
2011	0.32	-9.41%
2010	0.35	-8.79%
2009	0.39	9.70%
2008	0.35	-41.73%
2007	0.60	0.00%

År

P/S-tal

Ändra

2026 (TTM)

0.52

-57.06%

2024

1.20

-21.39%

2023

1.52

-7.79%

2022

1.65

-28.83%

2021

2.32

-30.28%

2020

3.33

-22.20%

2019

4.28

24.56%

2018

3.43

173.39%

2017

1.26

20.04%

2016

1.05

-20.02%

2015

1.31

20.62%

2014

1.08

34.07%

2013

0.81

-0.50%

2012

0.81

155.32%

2011

0.32

-9.41%

2010

0.35

-8.79%

2009

0.39

9.70%

2008

0.35

-41.73%

2007

0.60

0.00%

Företag	P/S-tal	Skillnad i P/S-tal	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	1,399.98%	IN

Företag

P/S-tal

Skillnad i P/S-tal

Land